Business
Tier 2 and Tier 3 Doctors The Untapped Goldmine of Indian Pharma Marketing
For decades, Indian pharma marketing has revolved around Tier 1 cities. Mumbai, Delhi, Bangalore…
Tier 2 and Tier 3 Doctors: Pharma’s Untapped Growth Engine
For years, Indian pharma marketing has been obsessed with metros. Strategies are designed for…
Cutting Pharma Content Approval Cycles with Modular Ops
Every pharma marketer in India knows the feeling. A new campaign is planned, deadlines are set,…
The UCPMP 2024 Rulebook- What Pharma CMOs Need to Change in Marketing Ops
For years, Indian pharma operated in a grey zone where marketing practices were loosely…
Why Indian Pharma Keeps Failing at Digital Transformation
Digital Transformation is the buzzword that never dies in Indian pharma boardrooms. Every annual…
Omnichannel in Indian Pharma Beyond Emails and Rep Visits
The term omnichannel in Indian pharma gets thrown around so often that it risks losing meaning.…
What an HCP Engagement Program Really Means for Indian Pharma
In Indian pharma, budgets are rising but impact often feels invisible. Marketing leaders spend…
AI in Pharma: From Hype to Actions That Move the Needle
If you’re a pharma CMO in India, here’s the thing: AI in Pharma only pays off when it sits on…
MLR Delays Are Costing You Market Share: How Modular Content Fixes It
Every pharma CMO in India has a war story about MLR delays. Campaigns stuck for weeks because a…
